Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria
基于西罗莫司的免疫抑制疗法可改善符合杭州标准以外的肝细胞癌肝移植受者的预后。
期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm.2020.01.10
Ling, Sunbin; Feng, Tingting; Zhan, Qifan; Duan, Xin; Jiang, Guangjiang; Shen, Tian; Shan, Qiaonan; Xu, Shengjun; Ye, Qianwei; Liu, Peng; Cen, Beini; Zheng, Shusen; Xu, Xiao